Your browser doesn't support javascript.
loading
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results.
Wittmann, Daniela; Mehta, Akanksha; Bober, Sharon L; Zhu, Ziwei; Daignault-Newton, Stephanie; Dunn, Rodney L; Braun, Thomas M; Carter, Caroline; Duby, Ashley; Northouse, Laurel L; Koontz, Bridget F; Glodé, L Michael; Brandon, Jan; Bangs, Rick; McPhail, John; McPhail, Susan; Arab, Lenore; Paich, Kellie; Skolarus, Ted A; An, Lawrence C; Nelson, Christian J; Saigal, Christopher S; Chen, Ronald C; Mulhall, John P; Hawley, Sarah T; Hearn, Jason W D; Spratt, Daniel E; Pollack, Craig E.
Afiliación
  • Wittmann D; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Mehta A; Department of Urology, Emory University, Atlanta, Georgia.
  • Bober SL; Sexual Health Program, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zhu Z; Department of Psychiatry, Harvard University, Boston, Massachusetts.
  • Daignault-Newton S; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Dunn RL; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Braun TM; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Carter C; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Duby A; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Northouse LL; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Koontz BF; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Glodé LM; Department of Radiation Oncology, Duke University, Durham, North Carolina.
  • Brandon J; School of Medicine, Medical Oncology, University of Colorado, Aurora, Colorado.
  • Bangs R; Partner advocate, Bethesda, Maryland.
  • McPhail J; Patient advocate, Bethesda, Maryland.
  • McPhail S; Patient advocate, Bethesda, Maryland.
  • Arab L; Partner advocate, Bethesda, Maryland.
  • Paich K; Department of Urology, University of California Los Angeles, Los Angeles, California.
  • Skolarus TA; Movember Foundation, Los Angeles, California.
  • An LC; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Nelson CJ; VA Health Services Research & Development, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
  • Saigal CS; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Chen RC; Male Sexual and Reproductive Medicine Program, Memorial Sloan Kettering, New York, New York.
  • Mulhall JP; Psychiatry Service, New York, New York.
  • Hawley ST; Department of Urology, University of California Los Angeles, Los Angeles, California.
  • Hearn JWD; Department of Urology, University of California Los Angeles, Los Angeles, California.
  • Spratt DE; Center for Sexual and Reproductive Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pollack CE; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Cancer ; 128(7): 1513-1522, 2022 Apr 01.
Article en En | MEDLINE | ID: mdl-34985771
ABSTRACT

BACKGROUND:

Despite significant sexual dysfunction and distress after localized prostate cancer treatment, patients typically receive only physiologic erectile dysfunction management. The authors performed a randomized controlled trial of an online intervention supporting couples' posttreatment recovery of sexual intimacy.

METHODS:

Patients treated with surgery, radiation, or combined radiation and androgen deprivation therapy who had partners were recruited and randomized to an online intervention or a control group. The intervention, tailored to treatment type and sexual orientation, comprised 6 modules addressing expectations for sexual and emotional sequelae of treatment, rehabilitation, and guidance toward sexual intimacy recovery. Couples, recruited from 6 sites nationally, completed validated measures at the baseline and 3 and 6 months after treatment. Primary outcome group differences were assessed with t tests for individual outcomes.

RESULTS:

Among 142 randomized couples, 105 patients (mostly surgery) and 87 partners completed the 6-month survey; this reflected challenges with recruitment and attrition. There were no differences between the intervention and control arms in Patient-Reported Outcomes Measurement Information System Global Satisfaction With Sex Life scores 6 months after treatment (the primary outcome). Three months after treatment, intervention patients and partners reported more engagement in penetrative and nonpenetrative sexual activities than controls. More than 73% of the intervention participants reported high or moderate satisfaction with module content; more than 85% would recommend the intervention to other couples.

CONCLUSIONS:

Online psychosexual support for couples can help couples to connect and experience sexual pleasure early after treatment despite patients' sexual dysfunction. Participants' high endorsement of the intervention reflects the importance of sexual health support to couples after prostate cancer treatment. LAY

SUMMARY:

This study tested a web-based program supporting couples' sexual recovery of sexual intimacy after prostate cancer treatment. One hundred forty-two couples were recruited and randomly assigned to the program (n = 60) or to a control group (n = 82). The program did not result in improvements in participants' satisfaction with their sex life 6 months after treatment, but couples in the intervention group engaged in sexual activity sooner after treatment than couples in the control group. Couples evaluated the program positively and would recommend it to others facing prostate cancer treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_sistemas_informacao_saude / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Próstata / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Guideline Aspecto: Patient_preference Límite: Humans / Male Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_sistemas_informacao_saude / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Próstata / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Guideline Aspecto: Patient_preference Límite: Humans / Male Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article
...